Influence of half-life and smoking/nonsmoking ratio on biomarker consistency between Waves 1 and 2 of the Population Assessment of Tobacco and Health Study.
David L AshleyWanzhe ZhuDeepak BhandariLanqing WangJune FengYuesong WangLei MengBaoyun XiaJeffery M JarrettJoanne T ChangHeather L KimmelBenjamin C BlountPublished in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2023)
Biomarkers measured in the PATH Study provide consistent sample-to-sample measures from which to investigate the association of adverse health outcomes with the characteristics of cigarettes and their use.